Chavez, Edlyn .
HRN: 22-81-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2023
CEFTRIAXONE 1G (VIAL)
04/04/2023
04/04/2023
IVT
2g
Prior To OR Use
For Stat Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes